| 1 |
Carbó M, Chaturvedi P, Álvarez A, Pineda-Cevallos D, Ghatak A, González PR, Cañal MJ, Weckwerth W, Valledor L. Ferroptosis is the key cellular process mediating Bisphenol A responses in Chlamydomonas and a promising target for enhancing microalgae-based bioremediation. J Hazard Mater 2023;448:130997. [PMID: 36860062 DOI: 10.1016/j.jhazmat.2023.130997] [Reference Citation Analysis]
|
| 2 |
Yang Y, Tao Y, Li Z, Cui Y, Zhang J, Zhang Y. Agrochemical-mediated cardiotoxicity in zebrafish embryos/larvae: What we do and where we go. Critical Reviews in Environmental Science and Technology 2023. [DOI: 10.1080/10643389.2023.2174771] [Reference Citation Analysis]
|
| 3 |
Qiao O, Wang X, Wang Y, Li N, Gong Y. Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment. J Adv Res 2023:S2090-1232(23)00029-2. [PMID: 36702249 DOI: 10.1016/j.jare.2023.01.016] [Reference Citation Analysis]
|
| 4 |
Zhang X, Flaws JA, Spinella MJ, Irudayaraj J. The Relationship between Typical Environmental Endocrine Disruptors and Kidney Disease. Toxics 2022;11. [PMID: 36668758 DOI: 10.3390/toxics11010032] [Reference Citation Analysis]
|
| 5 |
Wu J, Cai H, Lei Z, Li C, Hu Y, Zhang T, Zhu H, Lu Y, Cao J, Hu X. Expression pattern and diagnostic value of ferroptosis-related genes in acute myocardial infarction. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.993592] [Reference Citation Analysis]
|
| 6 |
Liu Y, Wang J, Badr DA. Ferroptosis, a Rising Force against Renal Fibrosis. Oxidative Medicine and Cellular Longevity 2022;2022:1-12. [DOI: 10.1155/2022/7686956] [Reference Citation Analysis]
|
| 7 |
Yan K, Hou T, Zhu L, Ci X, Peng L. PM2.5 inhibits system Xc- activity to induce ferroptosis by activating the AMPK-Beclin1 pathway in acute lung injury. Ecotoxicol Environ Saf 2022;245:114083. [PMID: 36137421 DOI: 10.1016/j.ecoenv.2022.114083] [Reference Citation Analysis]
|
| 8 |
Sun Q, Zhen P, Li D, Liu X, Ding X, Liu H. Amentoflavone promotes ferroptosis by regulating reactive oxygen species (ROS) /5’AMP-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) to inhibit the malignant progression of endometrial carcinoma cells. Bioengineered 2022;13:13269-79. [DOI: 10.1080/21655979.2022.2079256] [Reference Citation Analysis]
|
